PT - JOURNAL ARTICLE AU - McCuddy, Micheala AU - Kelkar, Praful AU - Zhao, Yu AU - Wicklund, David TI - Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 infection: A Case Series AID - 10.1101/2020.07.15.20126730 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.15.20126730 4099 - http://medrxiv.org/content/early/2020/07/17/2020.07.15.20126730.short 4100 - http://medrxiv.org/content/early/2020/07/17/2020.07.15.20126730.full AB - Objective To report three patients infected with COVID-19 with severe respiratory syndrome requiring intubation, who developed acute demyelinating encephalomyelitis (ADEM).Method Patient data were obtained from medical records from the North Memorial Health Hospital, Robbinsdale, MN, USAResults Three patients (two men and one woman, aged 38 - 63) presented with fatigue, cough and fever leading to development of acute respiratory distress syndrome secondary to COVID-19 infection requiring intubation and ventilatory support. Two patients were unresponsive, one with strong eye deviation to the left and the third patient had severe diffuse weakness. MRI in all patients showed findings consistent with ADEM. CSF showed elevated protein in all patients with normal cell count and no evidence of infection, including negative COVID-19 PCR. All three of the patients received Convalescent plasma therapy for COVID-19. All patients were treated with intravenous corticosteroids and improved, although two responded minimally. Two patients treated with IVIG showed no further improvement.Conclusion Neurological complications from COVID-19 are being rapidly recognized. Our three cases highlight the occurrence of ADEM as a postinfectious/immune mediated complication of COVID-19 infection, which may be responsive to corticosteroid treatment. Early recognition of this complication and treatment is important to avoid long term complications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was involved in this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This was a retrospective case report. None of the patients identifiers are in the paper. The paper was reviewed by the IRB at North Memorial Hospital and it was determined that waiver of consent is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is maintained by the authors.